Who owns BlossomHill Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BLSM from SEC Form 13F filings across 39 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 39 institutions disclosed 16.9M shares of BlossomHill Therapeutics, Inc. worth $319.2M — about 91.2% of shares outstanding; the largest disclosed holder is Cormorant Asset Management, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
39
13F holders
$319.2M
value, 2026 filers
91.2%
of shares outstanding (16.9M sh)
39
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of BLSM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Cormorant Asset Management, LPNEW | 3.6M | $67.4M | 4.5% | 19.5% | new |
| 2 | ORBIMED ADVISORS LLCNEW | 2.7M | $50.6M | 0.9% | 14.6% | new |
| 3 | PERCEPTIVE ADVISORS LLCNEW | 1.8M | $33.8M | 0.6% | 9.8% | new |
| 4 | Vivo Capital, LLCNEW | 1.5M | $27.8M | 3.1% | 8.1% | new |
| 5 | DEERFIELD MANAGEMENT COMPANY, L.P.NEW | 1.4M | $27.0M | 0.4% | 7.8% | new |
| 6 | JPMORGAN CHASE & CONEW | 1.4M | $30.2M | 0.0% | 7.6% | new |
| 7 | Janus Henderson Group Ltd.NEW | 1.3M | $24.9M | 0.0% | 7.2% | new |
| 8 | FMR LLCNEW | 1.0M | $19.1M | 0.0% | 5.5% | new |
| 9 | VANGUARD CAPITAL MANAGEMENT LLCNEW | 433,302 | $8.1M | 0.0% | 2.3% | new |
| 10 | NEXTBio Capital Management LPNEW | 250,000 | $4.7M | 2.0% | 1.3% | new |
| 11 | SILVERARC CAPITAL MANAGEMENT, LLCNEW | 202,104 | $3.8M | 0.4% | 1.1% | new |
| 12 | Opaleye Management Inc.NEW | 175,000 | $3.3M | 0.4% | 0.9% | new |
| 13 | BlackRock, Inc.NEW | 147,686 | $2.8M | 0.0% | 0.8% | new |
| 14 | a16z Capital Management, L.L.C.NEW | 125,000 | $2.3M | 0.0% | 0.7% | new |
| 15 | GEODE CAPITAL MANAGEMENT, LLCNEW | 119,176 | $2.2M | 0.0% | 0.6% | new |
| 16 | Monashee Investment Management LLCNEW | 80,000 | $1.5M | 4.5% | 0.4% | new |
| 17 | AMERIPRISE FINANCIAL INCNEW | 73,691 | $1.4M | 0.0% | 0.4% | new |
| 18 | VANGUARD FIDUCIARY TRUST CONEW | 60,281 | $1.1M | 0.0% | 0.3% | new |
| 19 | CITADEL ADVISORS LLCNEW | 55,000 | $1.0M | 0.0% | 0.3% | new |
| 20 | Ghisallo Capital Management LLCNEW | 50,000 | $932,000 | 0.0% | 0.3% | new |
| 21 | Birchview Capital, LPNEW | 50,000 | $932,000 | 0.5% | 0.3% | new |
| 22 | MILLENNIUM MANAGEMENT LLCNEW | 45,818 | $854,048 | 0.0% | 0.2% | new |
| 23 | GOLDMAN SACHS GROUP INCNEW | 30,805 | $574,205 | 0.0% | 0.2% | new |
| 24 | Walleye Capital LLCNEW | 28,659 | $534,204 | 0.0% | 0.2% | new |
| 25 | Squarepoint Ops LLCNEW | 23,150 | $431,516 | 0.0% | 0.1% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.